The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlphawave Ip Regulatory News (AWE)

Share Price Information for Alphawave Ip (AWE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 121.80
Bid: 120.80
Ask: 121.40
Change: -3.60 (-2.87%)
Spread: 0.60 (0.497%)
Open: 125.40
High: 125.40
Low: 118.60
Prev. Close: 125.40
AWE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction of Typographical Errors

2 May 2023 07:00

RNS Number : 9849X
Alphawave IP Group PLC
02 May 2023
 

ALPHAWAVE SEMI

 

LONDON, United Kingdom and TORONTO, Ontario, Canada 2 May 2023 - Alphawave IP Group plc (LSE: AWE, the "Company" or "Alphawave Semi") notes the following typographical errors in its preliminary results for the year ended 31 December 2022 published on 28 April 2023:

 

- Capitalised R&D, pages 4,11 and 12, US$7.5m. Amended to US$7.2m.

- Operating expenses, page 11, US$88.6m. Amended to US$86.6m.

- Cash generated from operating activities before tax, page 28, US$'000 (2,857). Amended to US$'000 7,818.

- Revenue contribution from the acquisition of OpenFive, page 74, US$70,644,000. Amended to US$70,827,000.

- Accrued revenue from WiseWave, page 5, US$14.9m. Amended to US$20.2m.

- Accrued expenses, page 64, $US4.0m. Amended to US$4.0m.

 

For the avoidance of doubt, these are typographical errors only and not changes resulting from the completion of the audit work.

 

An updated version of the RNS with the typographical errors amended is available on our website at https://awavesemi.com/wp-content/uploads/2023/04/FY-2022-Preliminary-Results-28.04.23-amended.pdf. The capitalised R&D amount in the FY 2022 Preliminary Results presentation available on our website has been updated as shown above.

 

About Alphawave Semi (LSE: AWE)

Alphawave Semi is a global leader in high-speed connectivity for the World's technology infrastructure. Faced with the exponential growth of data, Alphawave Semi's technology services a critical need: enabling data to travel faster, more reliably and with higher performance at lower power. We are a vertically integrated semiconductor company, and our IP, custom silicon, and connectivity products are deployed by global tier-one customers in data centres, compute, networking, AI, 5G, autonomous vehicles, and storage. Founded in 2017 by an expert technical team with a proven track record in licensing semiconductor IP, our mission is to accelerate the critical data infrastructure at the heart of our digital world. To find out more about Alphawave Semi, visit: awavesemi.com.

 

Alphawave Semi and the Alphawave Semi logo are trademarks of Alphawave IP Group plc. All rights reserved.

 

Contact Information

 

Alphawave Semi

 

John Lofton Holt, Executive Chairman

Jose Cano, Head of IR

ir@awavesemi.com

+44 (0) 20 7717 5877

Brunswick Group

Simone Selzer

Sarah West

alphawave@brunswickgroup.com

+44 (0) 20 7404 5959

Gravitate PR

Lisette Paras

Siddarth Nigam

alphawave@gravitatepr.com

+1 415 528 0468

 

 

Cautionary statement regarding forward-looking statements

 

This document may contain forward-looking statements which are made in good faith and are based on current expectations or beliefs, as well as assumptions about future events. You can sometimes, but not always, identify these statements by the use of a date in the future or such words as "will", "anticipate", "estimate", "expect", "project", "intend", "plan", "should", "may", "assume" and other similar words. By their nature, forward-looking statements are inherently predictive and speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. You should not place undue reliance on these forward-looking statements, which are not a guarantee of future performance and are subject to factors that could cause our actual results to differ materially from those expressed or implied by these statements. The Company undertakes no obligation to update any forward-looking statements contained in this document, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCNKDBKKBKBBPK
Date   Source Headline
1st Aug 202211:00 amRNSTotal Voting Rights
21st Jul 202212:14 pmRNSDirector/PDMR Shareholding
20th Jul 20223:01 pmRNSHolding(s) in Company
19th Jul 202211:43 amRNSHolding(s) in Company
19th Jul 202210:12 amRNSDirector/PDMR Shareholding
19th Jul 20227:00 amRNSQ2 2022 Trading and Business Update
18th Jul 202210:31 amRNSDirector/PDMR Shareholding
15th Jul 20223:50 pmRNSDirector/PDMR Shareholding
14th Jul 20222:31 pmRNSBlock listing Interim Review
14th Jul 20222:26 pmRNSDirector/PDMR Shareholding
13th Jul 202210:43 amRNSDirector/PDMR Shareholding
11th Jul 20223:00 pmRNSDirector/PDMR Shareholding
7th Jul 202211:02 amRNSDirector/PDMR Shareholding
6th Jul 20224:59 pmRNSHolding(s) in Company
6th Jul 202212:03 pmRNSDirector/PDMR Shareholding
5th Jul 20222:03 pmRNSDirector/PDMR Shareholding
1st Jul 20223:44 pmRNSHolding(s) in Company
1st Jul 20222:28 pmRNSTotal Voting Rights
1st Jul 20222:27 pmRNSDirector/PDMR Shareholding
29th Jun 20226:26 pmRNSDirector/PDMR Shareholding
24th Jun 20225:50 pmRNSHolding(s) in Company
20th Jun 20223:01 pmRNSDirector/PDMR Shareholding
17th Jun 20229:42 amRNSDirector/PDMR Shareholding
16th Jun 202210:13 amRNSDirector/PDMR Shareholding
15th Jun 20229:36 amRNSDirector/PDMR Shareholding
14th Jun 20228:10 amRNSDirector/PDMR Shareholding
13th Jun 20229:33 amRNSDirector/PDMR Shareholding
9th Jun 202212:11 pmRNSGrant of Awards to a PDMR
6th Jun 20223:10 pmRNSResult of AGM
1st Jun 202210:11 amRNSTotal Voting Rights
1st Jun 20227:01 amRNSJose Cano Joins Alphawave IP as Global Head of IR
26th May 202212:30 pmRNSDirector/PDMR Shareholding
23rd May 20225:59 pmRNSDirector/PDMR Shareholding
20th May 20221:38 pmRNSHolding(s) in Company
19th May 202210:24 amRNSDirector/PDMR Shareholding
13th May 20221:28 pmRNSReplacement: Director/PDMR Shareholding
13th May 20221:15 pmRNSDirector/PDMR Shareholding
12th May 20226:02 pmRNSDirector/PDMR Shareholding
12th May 20225:43 pmRNSHolding(s) in Company
11th May 20225:49 pmRNSDirector/PDMR Shareholding
11th May 20225:44 pmRNSReplacement: Director/PDMR Shareholding
10th May 20224:53 pmRNSDirector/PDMR Shareholding
10th May 20221:35 pmRNSPosting of Annual Report and Notice of AGM
3rd May 20223:16 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNSFull Year 2021 Results and Q1 2022 Trading Update
29th Apr 20227:00 amRNSFull Year 2021 Results and Q1 2022 Trading Update
14th Apr 20227:00 amRNSReporting Update
1st Apr 202212:13 pmRNSTotal Voting Rights
14th Mar 20227:00 amRNSAcquisition
3rd Mar 20224:48 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.